戻る Agenda
Outcomes as a Pathway to Value and Pharma, Payer, Provider Collaboration
Session Chair(s)
Richard Gliklich, MD
Founder
OM1, United States
A focus on value is driving efforts to improve outcomes and reduce costs. This session explores the use of real world data to predict treatment benefit, response and cost and the use of measurable outcomes for supporting contracting and clinical decisions.
Learning Objective : Describe standardized outcomes measurement practices and initiatives and their importance to getting to a partnered solution; Discuss how predictive analytics are being applied to real-world data to measure and predict outcomes; Identify opportunities for using real world and outcomes data for supporting formulary, access, and clinical decision making.
Speaker(s)
Developing and Leveraging Harmonized Outcome Measures in Depression
Elise Berliner, PHD
Oracle Life Sciences, United States
Global Senior Principal for Real World Evidence Strategy
Patient-Reported Outcomes, Experience, Quality, and Value-Based Payment
Rachel Dupre Brodie
Pacific Business Group on Health, United States
Senior Director, Measurement and Accountability